A Phase 2, Single-arm, Open-label, Study to Evaluate the Safety and Efficacy of MGTA-456 in Patients with Inherited Metabolic Disorders (IMD) Undergoing Hematopoietic Stem Cell (HSC) Transplantation (HSCT)
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Magenta Therapeutics
Start Date
October 30, 2018
End Date
September 30, 2020
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Magenta Therapeutics
Start Date
October 30, 2018
End Date
September 30, 2020